{"id":"W2243598500","doi":"10.1200/jco.2010.28.15_suppl.4677","title":"Initial feasibility and safety results from a phase II/III clinical trial to evaluate docetaxel (D) therapy in combination with zoledronic acid (ZA) ± strontium-89 (Sr89) in hormone-refractory prostate cancer patients: ISRCTN12808747.","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Adverse effect; Prostate cancer; Docetaxel; Zoledronic acid; Surgery; Cancer; Oncology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006947986,0.001343966,0.001792537,0.0004718378,0.000525661,0.001117622,0.001025031,0.001540858,0.006216394],"category_scores_gemma":[0.005019847,0.000604707,0.001896762,0.0005622799,0.001313192,0.0008424079,0.0005620013,0.002419985,0.001008039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00108135,"about_ca_system_score_gemma":0.003023349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001358025,"about_ca_topic_score_gemma":0.002893446,"domain_scores_codex":[0.9973897,0.001887277,0.0001447516,0.0001791009,0.0001872299,0.0002118944],"domain_scores_gemma":[0.9955794,0.001772931,0.0008932033,0.0002653263,0.0002670818,0.001222052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9319509,0.02326415,0.003634428,0.0006152975,0.001063365,0.0001728907,0.0002093993,0.001014953,0.007330731,0.0001558175,0.002395815,0.02819229],"study_design_scores_gemma":[0.6717713,0.3158509,0.007990211,0.00006804467,0.0007495933,0.0001416326,0.00005783821,0.0004451362,0.001102861,0.0001612545,0.001637682,0.00002350736],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767414,0.003506004,0.001357333,0.001013187,0.0001163108,0.009929879,0.003434934,0.00007370601,0.003827211],"genre_scores_gemma":[0.9752889,0.002406529,0.003599567,0.001834823,0.0002206611,0.008228702,0.006028398,0.00004790548,0.002344499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006947986,"threshold_uncertainty_score":0.03674489,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1711104149319097,"score_gpt":0.5361155780872329,"score_spread":0.3650051631553232,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}